mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |